Table 1.
Baseline Characteristics of Patients with Vasculitis.
| TAK (n = 70) | AAV (n = 47) | GCA (n = 59) | |
|---|---|---|---|
| Mean age, years (SD) | 33.2 (10.2) | 55.3 (14.7) | 71.2 (8.6) |
| Median age (range) | 34 (5 – 71) | 60 (19–77) | 72.5 (50 – 88) |
| Female sex | 59 (84%) | 25 (53%) | 41 (69%) |
| Median disease duration, months (Interquartile range) | 96.8 (21.8–325.5) | 45.3 (10.1–336.8) | 38.2 (15.6–77.5) |
| Mean prednisone dose, mg/day (SD) | 8.7 (14.3) | 8.5 (16.8) | 16.3 (18.9) |
| DMARD use | 63 (90%) | 41 (87%) | 48 (81%) |
| Cyclophosphamide use | 0 (0%) | 12 (26%) | 0 (0%) |
| Hematologic parameters | |||
| Hemoglobin (g/dL) (SD) | 12.8 (1.5) | 13.3 (1.63) | 13.04 (1.52) |
| Absolute Lymphocyte count (×103/mL) (SD) | 2.24 (1.0) | 1.42 (0.72) | 1.86 (1.07) |
| Relative Lymphocyte counts (SD) | 28.2 (12.3) | 19.0 (10.9) | 20.6 (12.0) |
| Absolute Neutrophil Count (×103/mL) (SD) | 5.6 (2.8) | 5.97 (2.62) | 7.07 (3.09) |
| Relative Neutrophil counts (SD) | 62.8 (14.1) | 70.5 (13.2) | 70.5 (14.9) |
| Absolute Monocyte Count (×103/mL) (SD) | 0.24 (0.03) | 0.57 (0.21) | 0.57 (0.23) |
| Relative Monocyte counts (SD) | 6.26 (2.50) | 7.43 (2.75) | 6.32 (2.79) |
| Platelet Counts (×103/mL) (SD) | 311 (82) | 259 (63) | 273 (78) |
| Median Neutrophil / Lymphocyte Ratio (Interquartile range) | 2.27 (1.38–3.40) | 3.90 (2.61–7.49) | 3.17 (1.86–8.85) |
Abbreviations: SD, standard deviation; IQR, interquartile range; DMARD, Disease-modifying antirheumatic drugs; %, relative